Sihuan Pharmaceutical Holdings Group Ltd. (HKG:0460)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
0.8150
0.00 (0.00%)
Aug 27, 2026, 1:52 PM HKT

HKG:0460 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
179.7-216.66-54.02-1,915416.51
Depreciation & Amortization
189.08228.34211.88338.77278.97
Other Amortization
36.2130.0914.3531.0330.4
Loss (Gain) From Sale of Assets
-17.19-5.22-7.38-200.07-56.82
Asset Writedown & Restructuring Costs
---1,338131.3
Loss (Gain) From Sale of Investments
-31.43-27.11-153.02279.36-8.44
Loss (Gain) on Equity Investments
-11.6115.2353.6280.88158.58
Stock-Based Compensation
9.03418.0289.0889.6759.35
Provision & Write-off of Bad Debts
51.956.35-7.9528.4436.51
Other Operating Activities
150.21-191.62-58.19-206.31-124.57
Change in Accounts Receivable
-690.78-268.55265.79-163.68-245.24
Change in Inventory
-195.48130.7837.74-60.44-226.81
Change in Accounts Payable
315.9928.49-198.81415.54195.75
Change in Unearned Revenue
-9.24128.016.38-46.0329.77
Operating Cash Flow
-23.56276.14199.4946.49665.29
Operating Cash Flow Growth
-38.43%329.07%-93.01%192.91%

Investing Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-58.35-70.71-125.35-402.46-601.02
Sale of Property, Plant & Equipment
1.73.7115.5414.353.13
Cash Acquisitions
6.19----153.38
Divestitures
13.8-14.9388.45-
Sale (Purchase) of Intangibles
-136.15-109.07-170.04-187.49-124.57
Sale (Purchase) of Real Estate
39.615.77-1.3--
Investment in Securities
-380.22562.17246.63-1,190151.15
Other Investing Activities
155.75285.65224.6538.22376.39
Investing Cash Flow
-296.48758.24169.88-1,661-337.57

Financing Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
272.41318.25385.59480.32836.08
Long-Term Debt Repaid
-279.94-649.98-416.97-328.05-545.63
Net Debt Issued (Repaid)
-7.53-331.73-31.38152.27290.46
Issuance of Common Stock
----2.74
Repurchase of Common Stock
-188.63-20.3-33.81--206.41
Common Dividends Paid
-90.89-177.08-298.56-130.62-122.89
Other Financing Activities
645.2-761.55-55.81924.32786.76
Financing Cash Flow
358.16-1,291-419.56-238.93750.66

Net Cash Flow

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
38.12-256.28-50.2-1,8541,078

Free Cash Flow

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-81.91205.4474.14-355.9764.28
Free Cash Flow Growth
-177.09%---
Free Cash Flow Margin
-3.13%10.81%3.98%-16.32%2.11%
Free Cash Flow Per Share
-0.010.020.01-0.040.01
Levered Free Cash Flow
-197.19-838.631,458-532.22-242.96
Unlevered Free Cash Flow
-71.2-666.791,626-400.23-169.61

Additional Metrics

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
48.1643.4653.9855.6827.93
Cash Income Tax Paid
184.5588.9283.8156.98203.53
Change in Working Capital
-579.518.74111.1145.4-246.53